{{Rsnum
|rsid=10757269
|Gene=CDKN2B-AS1
|Chromosome=9
|position=22072265
|Orientation=plus
|GMAF=0.3196
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=CDKN2B-AS1,LOC102724137
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 20.0 | 55.4 | 24.6
| HCB | 2.2 | 28.9 | 68.9
| JPT | 6.8 | 22.7 | 70.5
| YRI | 0.0 | 9.5 | 90.5
| ASW | 0.0 | 0.0 | 0.0
| CHB | 2.2 | 28.9 | 68.9
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22199011
|Trait=None
|Title=Association between chromosome 9p21 variants and the ankle-brachial index identified by a meta-analysis of 21 genome-wide association studies.
|RiskAllele=G
|Pval=9E-9
|OR=0.0045
|ORtxt=None
|OA=1
}}

{{PMID Auto
|PMID=24323119
|Title=The combination of 9p21.3 genotype and biomarker profile improves a peripheral artery disease risk prediction model
}}

{{on chip | FTDNA}}